Jiangsu Hansoh Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Explore linked clinical trials.59 results ยท Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506 | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-09-28 | NCT07844967 | |
| A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function. | To Compare the Pharmacokinetic (PK) Differences of HS-10504 Between Participants With Hepatic Impairment and Participants With Normal Hepatic Function | Not yet recruiting | Phase 1 | 2026-09-23 | NCT07836504 | |
| A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 3 | 2026-09-16 | NCT07822542 | |
| A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy | High-risk Non-muscle-invasive Bladder Cancer | Recruiting | Phase 1 / Phase 2 | 2026-09-04 | NCT07468851 | |
| Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI | Hemic and Lymphatic Diseases, anemia, hematologic disorder | Recruiting | Phase 4 | 2026-09-02 | NCT06946394 | |
| A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2026-08-31 | NCT06461156 | |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C Levels | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, metabolic disease | Not yet recruiting | Phase 1 | 2026-08-20 | NCT07777003 | |
| A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504 | Healthy Participants | Not yet recruiting | Phase 1 | 2026-08-18 | NCT07770217 | |
| A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis | Moderate to Severe Plaque Psoriasis | Not yet recruiting | Phase 2 | 2026-08-14 | NCT07765628 | |
| A Mass Balance Study of [14C]HS-10504 | Healthy Subjects | Not yet recruiting | Phase 1 | 2026-08-14 | NCT07764705 | |
| A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504 | Healthy Participants | Not yet recruiting | Phase 1 | 2026-08-14 | NCT07764692 | |
| A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Not yet recruiting | Phase 3 | 2026-08-12 | NCT07759869 | |
| Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 3 | 2026-08-10 | NCT07754123 | |
| A Phase I Study of Single and Multiple Doses of HS-20136-2 Injection in Healthy or Obese Participants | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 1 | 2026-07-21 | NCT07716241 | |
| An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer | non-small cell lung carcinoma | Not yet recruiting | Phase 1 | 2026-07-06 | NCT07685041 | |
| A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder | Dyssomnias, Sleep Disorders, Intrinsic, Sleeplessness, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Not yet recruiting | Phase 3 | 2026-06-30 | NCT07677384 | |
| A Study of HS-20136-2 in Healthy Participants | Healthy | Not yet recruiting | Phase 1 | 2026-06-01 | NCT07483437 | |
| Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors. | KRAS G12C Mutation Advanced Solid Tumor | Not yet recruiting | Phase 1 | 2026-05-29 | NCT07615413 | |
| A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese Participants and Chinese Participants With Mild Hypertension | cardiovascular disorder, hypertensive disorder, vascular disorder | Not yet recruiting | Phase 1 | 2026-05-27 | NCT07609875 | |
| MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH) | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 3 | 2026-05-22 | NCT04841811 | |
| A Study of HS-10506 in Chinese Patients With Insomnia Disorder | Dyssomnias, Sleep Disorders, Intrinsic, Sleeplessness, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Not yet recruiting | Phase 3 | 2026-05-14 | NCT07587385 | |
| A Study of HS-10587 in Patients With Advanced Solid Tumors | MTAP Deletion | Not yet recruiting | Phase 1 | 2026-05-05 | NCT07567859 | |
| A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Not yet recruiting | Phase 2 | 2026-04-28 | NCT07555054 | |
| A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult Participants | Healthy Participants | Not yet recruiting | Phase 1 | 2026-04-17 | NCT07535970 | |
| Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Recruiting | Phase 1 / Phase 2 | 2026-04-13 | NCT07470762 |